1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        North America Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        North America Typhoid Fever Vaccines Market – By Country

2.          North America Typhoid Fever Vaccines Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Typhoid Fever Vaccines Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        North America Typhoid Fever Vaccines Market - North America PEST Analysis

4.3        Expert Opinion

5.          North America Typhoid Fever Vaccines Market Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Increase in Number of Americans Travelling Outside North America

5.2        Key Restraints

5.2.1        Risks Associated with Typhoid Fever Vaccines

5.3        Key Market Opportunities

5.3.1        Increasing Pharmaceutical and Biopharmaceutical Industry

5.4        Future Trend

5.4.1        Initiatives to Reduce Typhoid Burden

5.5        Impact Analysis

6.          Typhoid Fever Vaccines Market – North America Analysis

6.1        North America Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7.          Typhoid Fever Vaccines Market – By Vaccine Type

7.1        Overview

7.2        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3        Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7        Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.          Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1        Overview

8.2        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1          Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3        Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.          Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1        North America: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        North America: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.4        North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018–2027 (USD Million)

9.1.5        North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.1.6        US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.6.3          US: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.7        Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.7.3          Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.8        Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.8.3          Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

10.       Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.       Company Profiles

11.1      Paxvax Inc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      PT Bio Farma

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      BIO-MED

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Sanofi

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      GlaxoSmithKline plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.            North America Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            North America Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.            US Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 4.            US Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.            Canada Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            Canada Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.            Mexico Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 8.            Mexico Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 9.            Glossary of Terms, North America Typhoid Fever Vaccines Market

LIST OF FIGURES

Figure 1.           Typhoid Fever Vaccines Market Segmentation

Figure 2.           North America Typhoid Fever Vaccines Market Overview

Figure 3.           Convex Segment Held Largest Share of Typhoid Fever Vaccines Market

Figure 4.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)

Figure 7.           North America : PEST Analysis

Figure 8.           Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 11.        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 16.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        North America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 19.        North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 20.        North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 21.        US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries